JP2021536482A5 - - Google Patents
Info
- Publication number
- JP2021536482A5 JP2021536482A5 JP2021512830A JP2021512830A JP2021536482A5 JP 2021536482 A5 JP2021536482 A5 JP 2021536482A5 JP 2021512830 A JP2021512830 A JP 2021512830A JP 2021512830 A JP2021512830 A JP 2021512830A JP 2021536482 A5 JP2021536482 A5 JP 2021536482A5
- Authority
- JP
- Japan
- Prior art keywords
- ring
- optionally substituted
- salt
- compound
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018167488 | 2018-09-07 | ||
| JP2018167488 | 2018-09-07 | ||
| PCT/JP2019/035233 WO2020050409A1 (en) | 2018-09-07 | 2019-09-06 | Heterocyclic compound |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021536482A JP2021536482A (ja) | 2021-12-27 |
| JP2021536482A5 true JP2021536482A5 (enExample) | 2022-09-14 |
| JP7448527B2 JP7448527B2 (ja) | 2024-03-12 |
Family
ID=68063002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512830A Active JP7448527B2 (ja) | 2018-09-07 | 2019-09-06 | ヘテロ環式化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11932657B2 (enExample) |
| EP (1) | EP3847176A1 (enExample) |
| JP (1) | JP7448527B2 (enExample) |
| KR (1) | KR102810086B1 (enExample) |
| CN (1) | CN112654627A (enExample) |
| AU (2) | AU2019335968B2 (enExample) |
| CA (1) | CA3109610A1 (enExample) |
| EA (1) | EA202190654A1 (enExample) |
| IL (1) | IL280821B2 (enExample) |
| SG (1) | SG11202101963XA (enExample) |
| TW (1) | TWI854995B (enExample) |
| WO (1) | WO2020050409A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7448527B2 (ja) | 2018-09-07 | 2024-03-12 | 大塚製薬株式会社 | ヘテロ環式化合物 |
| CA3155466A1 (en) | 2019-12-09 | 2021-06-17 | Otsuka Pharmaceutical Co., Ltd. | Acrylamide compounds |
| JP2023515128A (ja) | 2020-02-26 | 2023-04-12 | ジャガー セラピューティクス ピーティーイーリミテッド | Ａｈｒシグナル伝達の調節に有用なピリドピリミジン誘導体 |
| CN114181212B (zh) * | 2020-09-15 | 2023-06-06 | 山东轩竹医药科技有限公司 | 哒嗪酮类AhR抑制剂 |
| CN115215720B (zh) * | 2021-04-19 | 2023-08-22 | 中国科学院化学研究所 | 含薁单元的石墨烯纳米片段分子—薁并玉红省及其合成方法与应用 |
| WO2022228399A1 (zh) * | 2021-04-27 | 2022-11-03 | 山东轩竹医药科技有限公司 | 三并环类usp1抑制剂及其用途 |
| WO2023033741A1 (en) * | 2021-09-02 | 2023-03-09 | Jaguahr Therapeutics Pte Ltd | Compounds useful in modulation of ahr signalling |
| CN118076613A (zh) * | 2021-09-02 | 2024-05-24 | 捷豹治疗有限公司 | 可用于调节AhR信号传导的化合物 |
| WO2023033742A1 (en) * | 2021-09-02 | 2023-03-09 | Jaguahr Therapeutics Pte Ltd | Compounds useful in modulation of ahr signalling |
| CN119948035A (zh) | 2022-10-03 | 2025-05-06 | 捷豹治疗有限公司 | 可用于调节AhR信号传导的化合物 |
| WO2024090138A1 (ja) * | 2022-10-29 | 2024-05-02 | 松本油脂製薬株式会社 | 弾性繊維用処理剤及びその利用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20100362A1 (es) | 2008-10-30 | 2010-05-27 | Irm Llc | Derivados de purina que expanden las celulas madre hematopoyeticas |
| EA026134B1 (ru) | 2010-12-16 | 2017-03-31 | Ф. Хоффманн-Ля Рош Аг | Трициклические ингибиторы pi3k и способы их применения |
| WO2014138485A1 (en) | 2013-03-08 | 2014-09-12 | Irm Llc | Ex vivo production of platelets from hematopoietic stem cells and the product thereof |
| WO2016204256A1 (ja) | 2015-06-16 | 2016-12-22 | 国立大学法人京都大学 | 高機能性血小板の製造方法 |
| MX2019012431A (es) | 2017-04-21 | 2020-08-03 | Ikena Oncology Inc | Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos. |
| WO2019167973A1 (en) | 2018-03-01 | 2019-09-06 | Kyoto University | Cell cycle progression inhibitor |
| JP7448527B2 (ja) | 2018-09-07 | 2024-03-12 | 大塚製薬株式会社 | ヘテロ環式化合物 |
| CA3155466A1 (en) | 2019-12-09 | 2021-06-17 | Otsuka Pharmaceutical Co., Ltd. | Acrylamide compounds |
| JP2022188761A (ja) | 2021-06-09 | 2022-12-21 | 大塚製薬株式会社 | 窒素原子含有複素環化合物を用いる血小板産生方法 |
-
2019
- 2019-09-06 JP JP2021512830A patent/JP7448527B2/ja active Active
- 2019-09-06 CN CN201980058108.7A patent/CN112654627A/zh active Pending
- 2019-09-06 IL IL280821A patent/IL280821B2/en unknown
- 2019-09-06 EA EA202190654A patent/EA202190654A1/ru unknown
- 2019-09-06 EP EP19773956.8A patent/EP3847176A1/en active Pending
- 2019-09-06 SG SG11202101963XA patent/SG11202101963XA/en unknown
- 2019-09-06 US US17/271,479 patent/US11932657B2/en active Active
- 2019-09-06 WO PCT/JP2019/035233 patent/WO2020050409A1/en not_active Ceased
- 2019-09-06 KR KR1020217009658A patent/KR102810086B1/ko active Active
- 2019-09-06 CA CA3109610A patent/CA3109610A1/en active Pending
- 2019-09-06 AU AU2019335968A patent/AU2019335968B2/en active Active
- 2019-09-06 TW TW108132216A patent/TWI854995B/zh active
-
2024
- 2024-01-18 US US18/416,261 patent/US20240208999A1/en active Pending
- 2024-06-04 AU AU2024203760A patent/AU2024203760A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100369899C (zh) | 具有抗癌活性的取代的吲唑 | |
| JP2013505948A5 (enExample) | ||
| JP2009523146A5 (enExample) | ||
| JP2015143283A5 (enExample) | ||
| JP2008523069A5 (enExample) | ||
| JP2004529161A5 (enExample) | ||
| JP2013539795A5 (enExample) | ||
| JP2008517983A5 (enExample) | ||
| AR036041A1 (es) | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen | |
| JP2019522628A5 (enExample) | ||
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| JP2021523168A5 (enExample) | ||
| CO5650234A2 (es) | Antagonistas duales nk1/nk3´para tratar la esquizofrenia | |
| JP2019514879A (ja) | アシルスルホンアミドＮａＶ１．７阻害剤 | |
| JP2022548820A (ja) | プロテインキナーゼ阻害剤としてのイソキノリン誘導体 | |
| CA2521399A1 (en) | Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 | |
| ES2571741T3 (es) | Bencimidazoles sustituidos como inhibidores de Mps-1 quinasa | |
| JP2016535040A5 (enExample) | ||
| JPWO2021107065A5 (enExample) | ||
| JP2022534902A5 (enExample) | ||
| JP2012528839A5 (enExample) | ||
| JP2008525400A5 (enExample) | ||
| PE20090325A1 (es) | Nuevos compuestos ligandos del receptor de la adenosina a3 | |
| MX2012008147A (es) | Derivados de pirrazolopiridina. | |
| PL149903B1 (en) | Method of obtaining novel derivatives of 1h,3h-pyrol/1,2-c/thiazole |